Aspirin desensitization in patients undergoing percutaneous coronary intervention: a survey of current practice.


BACKGROUND Aspirin remains the mainstay of anti-platelet therapy in cardiac patients. However, if a patient is allergic to aspirin and dual anti-platelet therapy is indicated - such as with percutaneous coronary intervention (PCI), then there is no clear guidance. One possibility is aspirin desensitization. A variety of protocols exist for the rapid… (More)
DOI: 10.5603/CJ.2013.0025


2 Figures and Tables